2012
DOI: 10.1016/j.ajog.2012.06.080
|View full text |Cite
|
Sign up to set email alerts
|

A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
45
0
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 63 publications
(49 citation statements)
references
References 23 publications
3
45
0
1
Order By: Relevance
“…Patient selection was detailed in a previous study. 3 A total of 18,294 patients with histologically proven EC who underwent at least hysterectomy and extensive lymphadenectomy (910 regional LNs removed) were selected.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Patient selection was detailed in a previous study. 3 A total of 18,294 patients with histologically proven EC who underwent at least hysterectomy and extensive lymphadenectomy (910 regional LNs removed) were selected.…”
Section: Methodsmentioning
confidence: 99%
“…Patient characteristics have been reported previously. 3 Four hundred ninety-nine patients from a multicentric database were used for validation of the models. Patient characteristics are summarized in Table 1.…”
Section: Models Developmentmentioning
confidence: 99%
See 1 more Smart Citation
“…Several authors have proposed different scores in order to predict LN metastasis [45][46][47][48][49][50][51][52][53] (table 2).…”
Section: Scores To Predict Ln Metastasismentioning
confidence: 99%
“…Notwithstanding, in the article of Bendifallah et al, 4 the authors suggested that primary tumor characteristics between patients with lymph node micrometastases and with macrometastases are significantly different. By applying a probability nomogram, they argue that the frequency of micrometastases seems to occur earlier and in tumors with lower oncological aggressiveness, suggesting that micrometastasis could represent an ''intermediate state'' between disease-free lymph node and macrometastasis.…”
mentioning
confidence: 98%